• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肿瘤性疾病的股骨近端关节成形术系统评价

Systematic review of proximal femoral arthroplasty for non-neoplastic conditions.

作者信息

Korim Muhammad T, Esler Colin N A, Ashford Robert U

机构信息

Leicester Orthopaedics, University Hospitals of Leicester NHS Trust, Leicester, UK.

Leicester Orthopaedics, University Hospitals of Leicester NHS Trust, Leicester, UK; Academic Orthopaedics, Trauma & Sports Medicine, University of Nottingham, Nottingham, UK.

出版信息

J Arthroplasty. 2014 Nov;29(11):2117-21. doi: 10.1016/j.arth.2014.06.012. Epub 2014 Jun 21.

DOI:10.1016/j.arth.2014.06.012
PMID:25115232
Abstract

Proximal femoral arthroplasty (PFA) is an established treatment modality following oncological resection. Increasingly, these prostheses are being used for non-neoplastic conditions such as fractures and bone loss associated with septic or aseptic loosening. We performed a systematic review of the literature to determine the failure rates, mortality rates and hip outcome scores when PFAs were used in non-neoplastic conditions. There were 14 studies with an average follow-up of 3.8 years (range 0-14 years) describing 356 PFAs. Re-operation for any reason occurred in 23.8% (85/356) of cases. The most common complications were dislocation (15.7%) and infection (7.6%). The mortality rate ranged from 0% to 40%. PFA provides an acceptable surgical solution when confronted with massive bone loss, but it has a high re-operation rate for dislocation and infection.

摘要

股骨近端关节成形术(PFA)是肿瘤切除术后一种既定的治疗方式。越来越多地,这些假体被用于非肿瘤性疾病,如与感染性或无菌性松动相关的骨折和骨质流失。我们对文献进行了系统回顾,以确定PFA用于非肿瘤性疾病时的失败率、死亡率和髋关节结局评分。有14项研究,平均随访3.8年(范围0至14年),描述了356例PFA。23.8%(85/356)的病例因任何原因进行了再次手术。最常见的并发症是脱位(15.7%)和感染(7.6%)。死亡率范围为0%至40%。当面对大量骨质流失时,PFA提供了一种可接受的手术解决方案,但它因脱位和感染而有较高的再次手术率。

相似文献

1
Systematic review of proximal femoral arthroplasty for non-neoplastic conditions.非肿瘤性疾病的股骨近端关节成形术系统评价
J Arthroplasty. 2014 Nov;29(11):2117-21. doi: 10.1016/j.arth.2014.06.012. Epub 2014 Jun 21.
2
What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity?改良杯笼技术治疗骨盆不连续性的功能、影像学和生存结果如何?
Clin Orthop Relat Res. 2024 Dec 1;482(12):2149-2160. doi: 10.1097/CORR.0000000000003186. Epub 2024 Jul 9.
3
What Are the Complications, Reconstruction Survival, and Functional Outcomes of Modular Prosthesis and Allograft-prosthesis Composite for Proximal Femur Reconstruction in Children With Primary Bone Tumors?对于原发性骨肿瘤患儿的股骨近端重建,模块化假体及同种异体骨-假体复合物的并发症、重建存活率及功能结果如何?
Clin Orthop Relat Res. 2025 Mar 1;483(3):455-469. doi: 10.1097/CORR.0000000000003245. Epub 2024 Sep 3.
4
What Is the Cumulative Incidence of Femoral Stem Revision and Stem Complication in Cemented and Uncemented Hip Arthroplasty for Proximal Femoral Metastatic Bone Disease?对于股骨近端转移性骨病,骨水泥型和非骨水泥型髋关节置换术中股骨柄翻修及柄并发症的累积发生率是多少?
Clin Orthop Relat Res. 2025 Jun 10. doi: 10.1097/CORR.0000000000003541.
5
Are There Differences in Performance Among Femoral Stem Brands Utilized in Cementless Hemiarthroplasty for Treatment of Geriatric Femoral Neck Fractures?在用于治疗老年股骨颈骨折的非骨水泥半髋关节置换术中,不同品牌的股骨柄在性能上是否存在差异?
Clin Orthop Relat Res. 2025 Feb 1;483(2):253-264. doi: 10.1097/CORR.0000000000003222. Epub 2024 Aug 15.
6
Is 18 F-fluoride PET/CT an Accurate Tool to Diagnose Loosening After Total Joint Arthroplasty?18F-氟化物PET/CT是诊断全关节置换术后假体松动的准确工具吗?
Clin Orthop Relat Res. 2025 Mar 1;483(3):415-428. doi: 10.1097/CORR.0000000000003228. Epub 2024 Sep 11.
7
Composite Reconstruction With Irradiated Autograft Plus Total Hip Replacement After Type II Pelvic Resections for Tumors Is Feasible but Fraught With Complications.肿瘤Ⅱ型骨盆切除术后采用同种异体骨移植加全髋关节置换术进行复合重建是可行的,但并发症多。
Clin Orthop Relat Res. 2024 Oct 1;482(10):1825-1835. doi: 10.1097/CORR.0000000000003097. Epub 2024 Apr 26.
8
Total femur replacement in revision arthroplasty for non-oncologic patients: a systematic review.非肿瘤患者翻修关节成形术中全股骨置换:一项系统评价
Eur J Orthop Surg Traumatol. 2025 Mar 12;35(1):112. doi: 10.1007/s00590-025-04226-3.
9
Risk of revision and dislocation in single, dual mobility and large femoral head total hip arthroplasty: systematic review and network meta-analysis.单动、双动及大股骨头全髋关节置换术的翻修及脱位风险:系统评价与网状Meta分析
Eur J Orthop Surg Traumatol. 2018 Apr;28(3):445-455. doi: 10.1007/s00590-017-2073-y. Epub 2017 Nov 8.
10
Surgical Hip Dislocation in the Era of Hip Arthroscopy Demonstrates High Survivorship and Improvements in Patient-reported Outcomes for Complex Femoroacetabular Impingement.关节镜时代的髋关节脱位手术具有高存活率,并改善了复杂型股骨髋臼撞击症患者的报告结局。
Clin Orthop Relat Res. 2024 Sep 1;482(9):1671-1682. doi: 10.1097/CORR.0000000000003032. Epub 2024 Mar 21.

引用本文的文献

1
Proximal femur replacement in oncologic lesion: hemiarthroplasty vs total hip arthroplasty-a multicentric retrospective study.肿瘤性病变中股骨近端置换:半髋关节置换术与全髋关节置换术的多中心回顾性研究
J Orthop Surg Res. 2025 May 26;20(1):515. doi: 10.1186/s13018-025-05910-0.
2
Characteristics and Epidemiology of Megaprostheses Infections: A Systematic Review.巨型假体感染的特征与流行病学:一项系统综述
Healthcare (Basel). 2024 Jun 27;12(13):1283. doi: 10.3390/healthcare12131283.
3
Survival and Results after Resection and Reconstruction with Megaprosthesis at the Hip in Octogenarians.
老年患者髋关节置换术后使用大假体进行切除与重建的生存率及结果
J Clin Med. 2023 Dec 17;12(24):7740. doi: 10.3390/jcm12247740.
4
Megaprosthesis use in Paprosky III/IV femoral defects in non-oncological patients: analysis of survival, clinical, and functional outcomes after an average follow-up of five years.非肿瘤患者中使用大假体治疗Paprosky III/IV型股骨缺损:平均五年随访后的生存率、临床及功能结果分析
Eur J Orthop Surg Traumatol. 2024 Feb;34(2):1183-1192. doi: 10.1007/s00590-023-03783-9. Epub 2023 Nov 25.
5
Megaprosthesis in Non-Oncologic Settings-A Systematic Review of the Literature.非肿瘤学环境中的大型假体——文献系统综述
J Clin Med. 2023 Jun 20;12(12):4151. doi: 10.3390/jcm12124151.
6
The major proximal femoral defects: megaprosthesis in non oncological patients - A case series.主要股骨近端缺损:非肿瘤患者的大假体置换——病例系列
Orthop Rev (Pavia). 2023 Jan 28;15:38432. doi: 10.52965/001c.38432. eCollection 2023.
7
Apparent trends in the use of femoral megaprostheses: an analysis from the National Joint Registry.股骨大型假体使用的明显趋势:来自国家关节注册中心的分析
Arthroplasty. 2022 Dec 1;4(1):50. doi: 10.1186/s42836-022-00150-7.
8
[Strategies for stem revision : Surgery planning, implant removal and reimplantation].[翻修策略:手术规划、植入物取出与重新植入]
Orthopadie (Heidelb). 2023 Jan;52(1):21-34. doi: 10.1007/s00132-022-04277-y. Epub 2022 Jul 8.
9
The Performances of Conventional Titanium and Silver-Coated Megaprostheses in Non-oncological and Post-oncological Patients: An Analysis of Infection Failures in 142 Patients.传统钛合金和银涂层大假体在非肿瘤及肿瘤术后患者中的性能:142例患者感染失败情况分析
Arch Bone Jt Surg. 2022 May;10(5):439-446. doi: 10.22038/ABJS.2021.58351.2889.
10
Revision arthroplasty with megaprosthesis after Girdlestone procedure for periprosthetic joint infection as an option in massive acetabular and femoral bone defects.Girdlestone 术后假体周围感染的翻修关节成形术,使用大型髋臼和股骨骨缺损的 megaprosthesis 作为一种选择。
Acta Biomed. 2022 Mar 10;92(S3):e2021531. doi: 10.23750/abm.v92iS3.12160.